Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis
Piotr Tylicki, Karolina Polewska, Aleksander Och, Anna Susmarska, Ewelina Puchalska-Reglińska, Aleksandra Parczewska, Bogdan Biedunkiewicz, Krzysztof Szabat, Marcin Renke, Leszek Tylicki, Alicja Dębska-Ślizień
Viruses, doi:10.3390/v14030451
The group most at risk of death due to COVID-19 are patients on maintenance hemodialysis (HD). The study aims to describe the clinical course of the early phase of SARS-CoV-2 infection and find predictors of the development of COVID-19 severe pneumonia in this population. This is a case series of HD nonvaccinated patients with COVID-19 stratified into mild pneumonia and severe pneumonia group according to the chest computed tomography (CT) pneumonia total severity score (TSS) on admission. Epidemiological, demographic, clinical, and laboratory data were obtained from hospital records. 85 HD patients with a mean age of 69.74 (13.19) years and dialysis vintage of 38 (14-84) months were included. On admission, 29.14% of patients had no symptoms, 70.59% reported fatigue followed by fever-44.71%, shortness of breath-40.0%, and cough-30.59%. 20% of the patients had finger oxygen saturation less than 90%. In 28.81% of patients, pulmonary parenchyma was involved in at least 25%. The factors associated with severe pneumonia include fever, low oxygen saturation and arterial partial pressure of oxygen, increased C-reactive protein and ferritin serum levels, low blood count of lymphocytes as well as chronic treatment with angiotensin converting enzyme inhibitors; while the chronic active vitamin D treatment was associated with mild pneumonia. In conclusion, even though nearly one-third of the patients were completely asymptomatic, while the remaining usually reported only single symptoms, a large percentage of them had extensive inflammatory changes at diagnosis with SARS-CoV-2 infection. We identified potential predictors of severe pneumonia, which might help individualize pharmacological treatment and improve clinical outcomes.
Supplementary Materials: The following supporting information can be downloaded at: https://www. mdpi.com/article/10.3390/v14030451/s1, Table S1
References
Ambardar, Hightower, Huprikar, Chung, Singhal et al., Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic, J. Clin. Med,
doi:10.3390/jcm10112452Bayraktaroglu, Cinkooglu, Ceylan, Savas, The novel coronavirus pneumonia (COVID-19): A pictorial review of chest CT features, Diagn. Interv. Radiol,
doi:10.5152/dir.2020.20304Bernheim, Mei, Huang, Yang, Fayad et al., Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection, Radiology,
doi:10.1148/radiol.2020200463Biedunkiewicz, Tylicki, Puchalska-Regli Ńska, Ąbrowska, Ślizie Ń et al., SARS-CoV-2 infection in vaccinated maintenance hemodialysis patients despite anti-spike seroconversion: A report of 3 breakthrough cases, Eur. J. Transl. Clin. Med,
doi:10.31373/ejtcm/143208Campi, Gennari, Merlotti, Mingiano, Frosali et al., Vitamin D and COVID-19 severity and related mortality: A prospective study in Italy, BMC Infect. Dis,
doi:10.1186/s12879-021-06281-7Chauss, Freiwald, Mcgregor, Yan, Wang et al., Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells, Nat. Immunol,
doi:10.1038/s41590-021-01080-3Chen, Wu, Chen, Yan, Yang et al., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study, BMJ,
doi:10.1136/bmj.m1091Chinapaka, Baba, Kandakatla, Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease, Sci. Rep
Creput, Fumeron, Toledano, Diaconita, Izzedine, COVID-19 in Patients Undergoing Hemodialysis: Prevalence and Asymptomatic Screening During a Period of High Community Prevalence in a Large Paris Center, Kidney Med,
doi:10.1016/j.xkme.2020.09.001Diaz, Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19, J. Travel Med,
doi:10.1093/jtm/taaa041Fabri, Stenger, Shin, Yuk, Liu et al., Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages, Sci. Transl. Med
Fernandez-De-Las-Penas, Palacios-Cena, Gomez-Mayordomo, Florencio, Cuadrado et al., Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis, Eur. J. Intern. Med,
doi:10.1016/j.ejim.2021.06.009Garcia-Vidal, Alonso, Camon, Cardozo, Albiach et al., Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19, J. Antimicrob. Chemother,
doi:10.1093/jac/dkab321Gibson, Davis, Zhu, Bowman-Kirigin, Walker et al., Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium, PLoS ONE,
doi:10.1371/journal.pone.0140370Goicoechea, Sanchez Camara, Macias, Munoz De Morales, Rojas et al., COVID-19: Clinical course and outcomes of 36 hemodialysis patients in Spain, Kidney Int,
doi:10.1016/j.kint.2020.04.031Guven, Gultekin, The effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: An observational cohort study, Eur. J. Clin. Nutr
Hasan, Haider, Stigler, Khan, Mccoy et al., The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020, Am. J. Trop. Med. Hyg,
doi:10.4269/ajtmh.20-1496Hilbrands, Duivenvoorden, Vart, Franssen, Hemmelder et al., COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration, Nephrol. Dial. Transplant,
doi:10.1093/ndt/gfaa261Hippisley-Cox, Tan, Coupland, Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people, Heart,
doi:10.1136/heartjnl-2020-317393Imai, Kuba, Rao, Huan, Guo et al., Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature,
doi:10.1038/nature03712Ketteler, Block, Evenepoel, Fukagawa, Herzog et al., Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), Kidney Int. Suppl,
doi:10.1016/j.kisu.2017.04.001Kim, Melgoza, Jiang, Guo, The effect of renin-angiotensin-aldosterone system inhibitors on organ-specific ace2 expression in zebrafish and its implications for COVID-19, Sci. Rep,
doi:10.1038/s41598-021-03244-5Lakkireddy, Gadiga, Malathi, Karra, Raju et al., None
Li, Wu, Wu, Guo, Chen et al., The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia, Investig. Radiol,
doi:10.1097/RLI.0000000000000672Marckmann, Agerskov, Thineshkumar, Bladbjerg, Sidelmann et al., Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D, Nephrol. Dial. Transplant,
doi:10.1093/ndt/gfs138Matias, Jorge, Ferreira, Borges, Aires et al., Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters, Clin. J. Am. Soc. Nephrol,
doi:10.2215/CJN.06510909Mejia, Medina, Cornejo, Morello, Vasquez et al., Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru, PLoS ONE
Mily, Rekha, Kamal, Akhtar, Sarker et al., Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: A dose finding study for treatment of tuberculosis, BMC Pulm. Med,
doi:10.1186/1471-2466-13-23Miskulin, Majchrzak, Tighiouart, Muther, Kapoian et al., Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial, J. Am. Soc. Nephrol
Och, Tylicki, Polewska, Puchalska-Regli Ńska, Parczewska et al., Persistent post-COVID-19 syndrome in hemodialyzed patients-a longitudinal cohort study from the North of Poland, J. Clin. Med,
doi:10.3390/jcm10194451Ojo, Balogun, Williams, Ojo, Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies, Pulm. Med,
doi:10.1155/2020/6175964Pan, Ye, Sun, Gui, Liang et al., Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19), Radiology,
doi:10.1148/radiol.2020200370Patti, Pellegrino, Ricciardi, Novara, Cotugno et al., Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review, Antibiotics
Petrak, Van Hise, Skorodin, Fliegelman, Chundi et al., Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2, Crit. Care Explor,
doi:10.1097/CCE.0000000000000395Petrilli, Jones, Yang, Rajagopalan, O'donnell et al., Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study, BMJ,
doi:10.1136/bmj.m1966Petrulewicz, Rydzewska-Rosolowska, Fiderkiewicz, Wasinska-Krawczyk, Brzosko et al., The clinical course and short-term outcomes of coronavirus disease 2019 in a cohort of hemodialysis patients, Pol. Arch. Intern. Med,
doi:10.20452/pamw.15479Polack, Thomas, Kitchin, Absalon, Gurtman et al., Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine, N. Engl. J. Med,
doi:10.1056/NEJMoa2034577Pongpirul, Wiboonchutikul, Charoenpong, Panitantum, Vachiraphan et al., Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand, PLoS Negl. Trop. Dis,
doi:10.1371/journal.pntd.0008806Puchalska-Regli Ńska, Debska-Slizien, Biedunkiewicz, Tylicki, Polewska et al., Extremely high mortality in COVID-19 hemodialyzed patients before the anti-SARS-CoV-2 vaccination era. Large database from the North of Poland, Pol. Arch. Intern. Med,
doi:10.20452/pamw.16028Ramakrishnan, Nicolau, Jr, Langford, Mahdi et al., Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial, Lancet Respir. Med,
doi:10.1016/S2213-2600(21)00160-0Rodriguez-Morales, Cardona-Ospina, Gutierrez-Ocampo, Villamizar-Pena, Holguin-Rivera et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Travel Med. Infect. Dis,
doi:10.1016/j.tmaid.2020.101623Saeed, Gaba, Shah, Al Helali, Raidullah et al., Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19
Segala, Bavaro, Di Gennaro, Salvati, Marotta et al., Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review, Viruses,
doi:10.3390/v13112110Shi, Han, Jiang, Cao, Alwalid et al., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study, Lancet Infect. Dis,
doi:10.1016/S1473-3099(20)30086-4Shi, Han, Zheng, Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China, Radiology,
doi:10.1148/radiol.2020200269Simon, Rubey, Treipl, Gromann, Hemedi et al., Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls, Nephrol. Dial. Transplant,
doi:10.1093/ndt/gfab179Singer, Vitamin D in dialysis: Defining deficiency and rationale for supplementation, Semin. Dial,
doi:10.1111/sdi.12010Sommerstein, Kochen, Messerli, Grani, Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?, J. Am. Heart Assoc,
doi:10.1161/JAHA.120.016509Stroehlein, Wallqvist, Iannizzi, Mikolajewska, Metzendorf et al., Vitamin D supplementation for the treatment of COVID-19: A living systematic review, Cochrane Database Syst. Rev,
doi:10.1002/14651858.CD015043Stumpf, Siepmann, Lindner, Karger, Schwobel et al., Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine, Lancet Reg. Health Eur
Surendra, Abdul Manaf, Hooi, Bavanandan, Mohamad Nor et al., Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis, BMC Nephrol,
doi:10.1186/s12882-019-1326-xTang, Tu, Xiong, Sun, Tian et al., Risk factors for the mortality of hemodialysis patients with COVID-19: A multicenter study from the overall hemodialysis population in Wuhan, Semin. Dial,
doi:10.1111/sdi.12995Turgutalp, Ozturk, Arici, Eren, Gorgulu et al., Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19, BMC Nephrol,
doi:10.1186/s12882-021-02233-0Tylicki, Biedunkiewicz, Dabrowska, Slizien, Tylicki et al., Humoral response to SARS-CoV-2 vaccination promises to improve the catastrophic prognosis of hemodialysis patients as a result of COVID-19: The COViNEPH Project, Pol. Arch. Intern. Med,
doi:10.20452/pamw.16069Tylicki, Puchalska-Regli Ńska, Tylicki, Och, Polewska et al., Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection, J. Clin. Med
Weinreich, Sivapalasingam, Norton, Ali, Gao et al., REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2035002Williamson, Walker, Bhaskaran, Bacon, Bates et al., Factors associated with COVID-19-related death using OpenSAFELY, Nature,
doi:10.1038/s41586-020-2521-4Yuan, Yin, Tao, Tan, Hu, Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China, PLoS ONE,
doi:10.1371/journal.pone.0230548
